JP2013040195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013040195A5 JP2013040195A5 JP2012230330A JP2012230330A JP2013040195A5 JP 2013040195 A5 JP2013040195 A5 JP 2013040195A5 JP 2012230330 A JP2012230330 A JP 2012230330A JP 2012230330 A JP2012230330 A JP 2012230330A JP 2013040195 A5 JP2013040195 A5 JP 2013040195A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- carbamazepine
- seizure
- cyclodextrin
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72269205P | 2005-09-30 | 2005-09-30 | |
| US60/722,692 | 2005-09-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008533754A Division JP5284096B2 (ja) | 2005-09-30 | 2006-10-02 | 新規非経口カルバマゼピン製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013040195A JP2013040195A (ja) | 2013-02-28 |
| JP2013040195A5 true JP2013040195A5 (enExample) | 2014-08-07 |
| JP5794966B2 JP5794966B2 (ja) | 2015-10-14 |
Family
ID=37906812
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008533754A Expired - Fee Related JP5284096B2 (ja) | 2005-09-30 | 2006-10-02 | 新規非経口カルバマゼピン製剤 |
| JP2012230330A Expired - Fee Related JP5794966B2 (ja) | 2005-09-30 | 2012-10-17 | 新規非経口カルバマゼピン製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008533754A Expired - Fee Related JP5284096B2 (ja) | 2005-09-30 | 2006-10-02 | 新規非経口カルバマゼピン製剤 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20070185054A1 (enExample) |
| EP (2) | EP1928464B1 (enExample) |
| JP (2) | JP5284096B2 (enExample) |
| CN (1) | CN101309691A (enExample) |
| AU (1) | AU2006299501B2 (enExample) |
| BR (1) | BRPI0616447A2 (enExample) |
| CA (1) | CA2624463C (enExample) |
| CY (1) | CY1115517T1 (enExample) |
| DK (1) | DK1928464T3 (enExample) |
| ES (2) | ES2475157T3 (enExample) |
| MX (1) | MX2008004287A (enExample) |
| NZ (1) | NZ567290A (enExample) |
| PL (1) | PL1928464T3 (enExample) |
| PT (1) | PT1928464E (enExample) |
| RU (2) | RU2455996C2 (enExample) |
| SI (1) | SI1928464T1 (enExample) |
| WO (1) | WO2007041524A2 (enExample) |
| ZA (1) | ZA200803332B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100204178A1 (en) | 2006-10-02 | 2010-08-12 | James Cloyd | Novel parenteral carbamazepine formulation |
| RU2464042C1 (ru) * | 2011-03-31 | 2012-10-20 | Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" | КЛАТРАТНЫЙ КОМПЛЕКС β-ЦИКЛОДЕКСТРИНА С ПРОИЗВОДНЫМ 5-ГИДРОКСИ-4-АМИНОМЕТИЛ-1-ЦИКЛОГЕКСИЛ(ИЛИ ЦИКЛОГЕПТИЛ)-3-АЛКОКСИКАРБОНИЛИНДОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО |
| US20140178479A1 (en) | 2011-08-12 | 2014-06-26 | Perosphere, Inc. | Concentrated Felbamate Formulations for Parenteral Administration |
| US11235020B2 (en) * | 2013-03-13 | 2022-02-01 | Abraham Palmer | Methods and compositions for inhibiting glyoxalase 1 (GLO1) |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
| MY200159A (en) * | 2016-12-14 | 2023-12-09 | Sk Biopharmaceuticals Co Ltd | Parenteral liquid preparation comprising carbamate compound |
| WO2020157257A1 (en) * | 2019-02-01 | 2020-08-06 | H. Lundbeck A/S | Injectable carbamazepine composition essentially free of 10-br-carbamazepine |
| US12383633B1 (en) | 2024-10-01 | 2025-08-12 | Zymeron Corporation | Injectable formulations of PARP inhibitors and uses thereof |
| CN120754274A (zh) * | 2025-07-15 | 2025-10-10 | 江苏鹏鹞药业有限公司 | 一种卡马西平的生产工艺及负载分散剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3459731A (en) | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
| US5231098A (en) * | 1987-06-26 | 1993-07-27 | Nihon Bayer Agrochem K.K. | Insecticidal nitro-substituted heterocyclic compounds |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US6546131B1 (en) | 1990-12-19 | 2003-04-08 | Canon Kabushiki Kaisha | Image processing method and apparatus for achieving tone reproduction suited to the image |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2713934B1 (fr) | 1993-12-22 | 1996-01-12 | Commissariat Energie Atomique | Utilisation de cyclodextrines aminées pour la solubilisation aqueuse de composés hydrophobes, en particulier de molécules pharmaceutiquement actives. |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| GB9721497D0 (en) | 1997-10-09 | 1997-12-10 | Ciba Geigy Ag | Organic compounds |
| AU772204B2 (en) | 1999-01-21 | 2004-04-22 | Bristol-Myers Squibb Company | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| KR20030041577A (ko) * | 2001-11-20 | 2003-05-27 | 디디에스텍주식회사 | 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물 |
| JP2006509788A (ja) | 2002-11-27 | 2006-03-23 | ファルマシア・コーポレーション | バルデコキシブの濃縮液体組成物 |
-
2006
- 2006-10-02 WO PCT/US2006/038508 patent/WO2007041524A2/en not_active Ceased
- 2006-10-02 ES ES06816054.8T patent/ES2475157T3/es active Active
- 2006-10-02 CA CA2624463A patent/CA2624463C/en active Active
- 2006-10-02 MX MX2008004287A patent/MX2008004287A/es active IP Right Grant
- 2006-10-02 SI SI200631794T patent/SI1928464T1/sl unknown
- 2006-10-02 ES ES12150783T patent/ES2708375T3/es active Active
- 2006-10-02 EP EP06816054.8A patent/EP1928464B1/en not_active Revoked
- 2006-10-02 PT PT68160548T patent/PT1928464E/pt unknown
- 2006-10-02 EP EP12150783.4A patent/EP2444090B1/en active Active
- 2006-10-02 DK DK06816054.8T patent/DK1928464T3/da active
- 2006-10-02 RU RU2008117161/15A patent/RU2455996C2/ru not_active IP Right Cessation
- 2006-10-02 JP JP2008533754A patent/JP5284096B2/ja not_active Expired - Fee Related
- 2006-10-02 AU AU2006299501A patent/AU2006299501B2/en not_active Ceased
- 2006-10-02 NZ NZ567290A patent/NZ567290A/en not_active IP Right Cessation
- 2006-10-02 BR BRPI0616447-1A patent/BRPI0616447A2/pt not_active IP Right Cessation
- 2006-10-02 US US11/542,520 patent/US20070185054A1/en not_active Abandoned
- 2006-10-02 PL PL06816054T patent/PL1928464T3/pl unknown
- 2006-10-02 CN CNA2006800428107A patent/CN101309691A/zh active Pending
-
2008
- 2008-04-15 ZA ZA2008/03332A patent/ZA200803332B/en unknown
-
2012
- 2012-04-02 RU RU2012112839/15A patent/RU2012112839A/ru not_active Application Discontinuation
- 2012-10-17 JP JP2012230330A patent/JP5794966B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-26 CY CY20141100467T patent/CY1115517T1/el unknown
-
2021
- 2021-10-14 US US17/501,287 patent/US20220265547A1/en not_active Abandoned
-
2023
- 2023-06-16 US US18/336,419 patent/US20240165125A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2923685C (en) | Application of r-ketamine and salt thereof as pharmaceuticals | |
| KR101900520B1 (ko) | 복합 조성물 | |
| MY162339A (en) | Nanoparticles loaded with chemotherapeutic antitumoral drug | |
| SG10201903210WA (en) | Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders | |
| CN106562952B (zh) | 氯胺酮在治疗重性抑郁障碍中的应用 | |
| JP2016535777A5 (enExample) | ||
| JP2013535437A5 (enExample) | ||
| RU2018121615A (ru) | Модуляторы активности комплемента | |
| JP6943994B2 (ja) | 神経精神系障害の治療のための組成物および方法 | |
| JP2016517421A5 (enExample) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| RU2010132581A (ru) | Способы терапии заболеваний легких | |
| KR20140025461A (ko) | 진행성 고형 종양의 치료 방법 | |
| JP2012502103A5 (enExample) | ||
| JP2016514688A5 (enExample) | ||
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| FI3352735T3 (fi) | Pitkitetysti vapauttavia olantsapiiniformulaatioita | |
| RU2013108390A (ru) | Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека | |
| RU2006124557A (ru) | Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний | |
| MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
| JP2011500589A5 (enExample) | ||
| CN115243686B (zh) | 丁基苯酞及其衍生物的用途 | |
| KR20100038061A (ko) | 리마프로스트를 함유하는, 암화학 요법에 기인하는 말초신경장애 예방, 치료 및/또는 증상 경감제 | |
| JP2015529196A5 (enExample) | ||
| CN107921019B (zh) | 2-(5s-甲基-2-氧代-4r-苯基-吡咯烷-1-基)-乙酰胺在治疗病情发作中的应用 |